Behandling af tilfældigt fund af gruppe B-streptokokker i urin hos gravide

Translated title of the contribution: Treatment of incidentally found group B streptococcus in urine of pregnant women

Martin Høhrmann Hangaard, Jan Stener Jørgensen, Hans Jørn Kolmos, Christina Anne Vinter

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Group B streptococcus (GBS) is a group of naturally occurring bacteria that colonises the anogenital region of every third pregnant woman. From the anogenital region they can colonise the urine and cause bacteriuria. It is well documented that treatment of GBS-bacteriuria with more than 104 colony forming units per millilitre (CFU/ml) reduces the risk of maternal and neonatal morbidity. There is, however, no clear evidence as summarised in this review that GBS-bacteriuria more than 104 CFU/ml increases the risk of maternal and neonatal morbidity which is why no treatment is warranted.
Translated title of the contributionTreatment of incidentally found group B streptococcus in urine of pregnant women
Original languageDanish
Article numberV12200968
JournalUgeskrift for Laeger
ISSN0041-5782
Publication statusE-pub ahead of print - 14. Jun 2021

Fingerprint

Dive into the research topics of 'Treatment of incidentally found group B streptococcus in urine of pregnant women'. Together they form a unique fingerprint.

Cite this